Plain language summary of how the order of ALK treatments affects lung cancer patients in everyday life

This Plain Language Summary of Publication article (PLSP) from Future Oncology shares results from a study on people with ALK-positive advanced lung cancer. Researchers looked at how the order of ALK inhibitor treatments affected patients in real-world settings and how long each treatment lasted when used first or second. The goal was to help doctors choose the best treatment plan for their patients.

Visit the site using this link to read the article.

This PLSP is based on an article called ‘Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancer’ and was published in Lung Cancer.

Visit ESMO using the link to read the original article.

• advanced NSCLC
• ALK TKIs
• lay summary
• plain language summary
• real-world data
• sequencing
• targeted therapy
• treatment effectiveness